{"id":714434,"date":"2022-11-22T16:37:24","date_gmt":"2022-11-22T21:37:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/"},"modified":"2022-11-22T16:37:24","modified_gmt":"2022-11-22T21:37:24","slug":"lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/","title":{"rendered":"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">AUSTIN, Texas, Nov.  22, 2022  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EZqLn-RC2M6dgBG7YDBRIy_vkxAQOaIqh-Qm4c6flfSXnn14SiyA2_RV4CdWOG2DkazyOv2o5HLhzsRpNi7wLNE2tLIprk590af5bj_3t7Q=\" rel=\"nofollow noopener\" target=\"_blank\">Lumos Pharma, Inc.<\/a>\u00a0(NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the Piper Sandler 34<sup>th<\/sup> Annual Healthcare Conference November 29<sup>th<\/sup> through December 1<sup>st<\/sup>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: middle;text-align: left;padding-left: 10.0px\">Event:\u00a0<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%\">\n            <strong>Piper Sandler 34<\/strong><br \/>\n            <sup><br \/>\n              <strong>th<\/strong><br \/>\n            <\/sup><br \/>\n            <strong> Annual Healthcare Conference \u2013 November 29<\/strong><br \/>\n            <sup><br \/>\n              <strong>th<\/strong><br \/>\n            <\/sup><br \/>\n            <strong> \u2013 December 1<\/strong><br \/>\n            <sup><br \/>\n              <strong>st<\/strong><br \/>\n            <\/sup>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px\">Presentation:<\/td>\n<td>Lumos Pharma Fireside Chat November 30<sup>th<\/sup> at 2:00-2:25 PM (EST)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px\">Webcast link:<\/td>\n<td>\n            <a href=\"https:\/\/event.webcasts.com\/starthere.jsp?ei=1583054&amp;tp_key=ea101c19d8\" rel=\"nofollow noopener\" target=\"_blank\">Here<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px\">1&#215;1 Meetings:<\/td>\n<td>Management will be available for one-on-one meetings on November 30<sup>th<\/sup><\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">The webcast for the presentation can also be found on the Company\u2019s website under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8CuBRsE8Z-gEN7BEwGwsOFS64tgclOD2Pzw66ags78UWY9s4KaXsyT5EbH2Lhfo-4lmIiR4esxvVN4SSvbHJ8XpHEIVcae9HtYh_ldYq2Tfp7Ed6neaI0mdK1Y8DYvffdlL3nZL7eBt8ny1LUDdA5Q==\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d in the Investors &amp; Media section. Please contact your Piper Sandler salesperson, or Lumos Pharma Investor Relations, to schedule one-on-one meetings with the management team during the conference or thereafter.<\/p>\n<p align=\"justify\">\n        <strong>About Lumos Pharma<\/strong>\n      <\/p>\n<p align=\"justify\">Lumos Pharma, Inc.\u00a0is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases.\u00a0Lumos Pharma\u00a0was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including\u00a0Deerfield Management, a fund managed by Blackstone Life Sciences,\u00a0Roche Venture Fund,\u00a0New Enterprise Associates\u00a0(NEA), Sant\u00e9 Ventures, and UCB. Lumos Pharma\u2019s lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2 clinical trial, the OraGrowtH210 Trial, a PK\/PD trial, the OraGrowtH212 Trial, and a switch trial, the OraGrowtH213 Trial for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to recombinant growth hormone injections that PGHD subjects otherwise endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4SbpueSg8l-ALHUbJlFlQ55l1lPNzLtxL1rb5AFKV39CtwogJ2A1kBEGNXL1zvFgz8AALcqjohK1wLrCkf2w14tgCgmxCT66i-XK96dcnCk=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/lumos-pharma.com\/<\/a>.<\/p>\n<p>Investor &amp; Media Contact:<\/p>\n<p>Lisa Miller<br \/>Lumos Pharma Investor Relations<br \/>512-792-5454<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=igCR7YcqGIe_XaSP4_-EvSytS-MIETLsvfAULZEq0qBG3b3GP0NLv5kn2AT-b3BaLB_ITE4BbI34Nngclvf8JUdH0syAmr38RrXrOwVyEvk=\" rel=\"nofollow noopener\" target=\"_blank\">ir@lumos-pharma.com<\/a><\/p>\n<p>Source: Lumos Pharma, Inc.<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MmVmMWMwZGQtOTk0MC00ZDM3LWE0MmItMTgxMGJhZGNlNmU1LTEwMjgxNTA=\/tiny\/Lumos-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; Lumos Pharma, Inc.\u00a0(NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the Piper Sandler 34th Annual Healthcare Conference November 29th through December 1st. Event:\u00a0 Piper Sandler 34 th Annual Healthcare Conference \u2013 November 29 th \u2013 December 1 st Presentation: Lumos Pharma Fireside Chat November 30th at 2:00-2:25 PM (EST) Webcast link: Here 1&#215;1 Meetings: Management will be available for one-on-one meetings on November 30th The webcast for the presentation can also be found on the Company\u2019s website under \u201cEvents &amp; Presentations\u201d in the Investors &amp; Media section. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-714434","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; Lumos Pharma, Inc.\u00a0(NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the Piper Sandler 34th Annual Healthcare Conference November 29th through December 1st. Event:\u00a0 Piper Sandler 34 th Annual Healthcare Conference \u2013 November 29 th \u2013 December 1 st Presentation: Lumos Pharma Fireside Chat November 30th at 2:00-2:25 PM (EST) Webcast link: Here 1&#215;1 Meetings: Management will be available for one-on-one meetings on November 30th The webcast for the presentation can also be found on the Company\u2019s website under \u201cEvents &amp; Presentations\u201d in the Investors &amp; Media section. &hellip; Continue reading &quot;Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T21:37:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference\",\"datePublished\":\"2022-11-22T21:37:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/\"},\"wordCount\":336,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/\",\"name\":\"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=\",\"datePublished\":\"2022-11-22T21:37:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference - Market Newsdesk","og_description":"AUSTIN, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; Lumos Pharma, Inc.\u00a0(NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the Piper Sandler 34th Annual Healthcare Conference November 29th through December 1st. Event:\u00a0 Piper Sandler 34 th Annual Healthcare Conference \u2013 November 29 th \u2013 December 1 st Presentation: Lumos Pharma Fireside Chat November 30th at 2:00-2:25 PM (EST) Webcast link: Here 1&#215;1 Meetings: Management will be available for one-on-one meetings on November 30th The webcast for the presentation can also be found on the Company\u2019s website under \u201cEvents &amp; Presentations\u201d in the Investors &amp; Media section. &hellip; Continue reading \"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-11-22T21:37:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference","datePublished":"2022-11-22T21:37:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/"},"wordCount":336,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/","name":"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=","datePublished":"2022-11-22T21:37:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjE5OSM1Mjc5MjgzIzIwMTY1Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=714434"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714434\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=714434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=714434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=714434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}